Having been an early investor in many recent successes such as Revolution Medicines, Peloton, and Parabilis Medicines, he describes his investment philosophy and focus on precision oncology companies. Plus, his early life, getting hands on experience in biotech at Micromet, and learning from some of the top investors and scientific advisors in the industry.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from BioVenture VoiCes with Chris Garabedian
Episode 47: Ally Bridge's Andrew Lam
Episode 46: Catalys Pacific's BT Slingsby
Episode 45: Catalio Capital Management's George Petrocheilos
Episode 44: BainCapital's Adam Koppel
Get summaries like this every morning.
Free AI-powered recaps of BioVenture VoiCes with Chris Garabedian and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.